BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33555595)

  • 1. Development of a huBLT Mouse Model to Study HCMV Latency, Reactivation, and Immune Response.
    Crawford LB; Caposio P
    Methods Mol Biol; 2021; 2244():343-363. PubMed ID: 33555595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Cytomegalovirus Induces Cellular and Humoral Virus-specific Immune Responses in Humanized BLT Mice.
    Crawford LB; Tempel R; Streblow DN; Kreklywich C; Smith P; Picker LJ; Nelson JA; Caposio P
    Sci Rep; 2017 Apr; 7(1):937. PubMed ID: 28428537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate Immune Reconstitution in Humanized Bone Marrow-Liver-Thymus (HuBLT) Mice Governs Adaptive Cellular Immune Function and Responses to HIV-1 Infection.
    Garcia-Beltran WF; Claiborne DT; Maldini CR; Phelps M; Vrbanac V; Karpel ME; Krupp KL; Power KA; Boutwell CL; Balazs AB; Tager AM; Altfeld M; Allen TM
    Front Immunol; 2021; 12():667393. PubMed ID: 34122425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signatures of T and B Cell Development, Functional Responses and PD-1 Upregulation After HCMV Latent Infections and Reactivations in Nod.Rag.Gamma Mice Humanized With Cord Blood CD34
    Theobald SJ; Khailaie S; Meyer-Hermann M; Volk V; Olbrich H; Danisch S; Gerasch L; Schneider A; Sinzger C; Schaudien D; Lienenklaus S; Riese P; Guzman CA; Figueiredo C; von Kaisenberg C; Spineli LM; Glaesener S; Meyer-Bahlburg A; Ganser A; Schmitt M; Mach M; Messerle M; Stripecke R
    Front Immunol; 2018; 9():2734. PubMed ID: 30524448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-transplantation of human fetal thymus, bone and CD34(+) cells into young adult immunodeficient NOD/SCID IL2Rγ(null) mice optimizes humanized mice that mount adaptive antibody responses.
    Chung YS; Son JK; Choi B; Joo SY; Lee YS; Park JB; Moon H; Kim TJ; Kim SH; Hong S; Chang J; Kang MS; Kim SJ
    Clin Immunol; 2015 Apr; 157(2):156-65. PubMed ID: 25725428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstitution of Human Cytomegalovirus-Specific CD4+ T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection.
    Gabanti E; Lilleri D; Ripamonti F; Bruno F; Zelini P; Furione M; Colombo AA; Alessandrino EP; Gerna G
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2192-2202. PubMed ID: 26260678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathymic injection of hematopoietic progenitor cells establishes functional T cell development in a mouse model of severe combined immunodeficiency.
    Tuckett AZ; Thornton RH; O'Reilly RJ; van den Brink MRM; Zakrzewski JL
    J Hematol Oncol; 2017 May; 10(1):109. PubMed ID: 28511686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model.
    Smith MS; Goldman DC; Bailey AS; Pfaffle DL; Kreklywich CN; Spencer DB; Othieno FA; Streblow DN; Garcia JV; Fleming WH; Nelson JA
    Cell Host Microbe; 2010 Sep; 8(3):284-91. PubMed ID: 20833379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective simultaneous quantification of human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants.
    Lilleri D; Gerna G; Fornara C; Lozza L; Maccario R; Locatelli F
    Blood; 2006 Aug; 108(4):1406-12. PubMed ID: 16614242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8-positive lymphocytes in graft-versus-host disease of humanized NOD.Cg-Prkdc(scid)Il2rg(tm1Wjl)/SzJ mice.
    Laing ST; Griffey SM; Moreno ME; Stoddart CA
    J Comp Pathol; 2015; 152(2-3):238-42. PubMed ID: 25670669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved B cell development in humanized NOD
    Jangalwe S; Shultz LD; Mathew A; Brehm MA
    Immun Inflamm Dis; 2016 Dec; 4(4):427-440. PubMed ID: 27980777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo monitoring of human cytomegalovirus-specific CD8(+) T-Cell responses using the QuantiFERON-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital.
    Fleming T; Dunne J; Crowley B
    J Med Virol; 2010 Mar; 82(3):433-40. PubMed ID: 20087937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
    Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
    Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition.
    Jouand N; Bressollette-Bodin C; Gérard N; Giral M; Guérif P; Rodallec A; Oger R; Parrot T; Allard M; Cesbron-Gautier A; Gervois N; Charreau B
    PLoS Pathog; 2018 Apr; 14(4):e1007041. PubMed ID: 29709038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of human cytomegalovirus-specific CD8+ T-cells in allogeneic haematopoietic stem cell transplant recipients using pentamer and interferon-γ-enzyme-linked immunospot assays.
    Liu A; Ma Y; Wu W; Chen X; Huang Y; Hu J; Liang H; Wang H; Yang R; Fan J
    J Clin Virol; 2013 Oct; 58(2):427-31. PubMed ID: 23910932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with 'humanized' antigen presentation as a new preclinical study tool.
    Lemmermann NA; Reddehase MJ
    Med Microbiol Immunol; 2016 Dec; 205(6):549-561. PubMed ID: 27539576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating Human T-Cell Therapy of Cytomegalovirus Organ Disease in HLA-Transgenic Mice.
    Thomas S; Klobuch S; Podlech J; Plachter B; Hoffmann P; Renzaho A; Theobald M; Reddehase MJ; Herr W; Lemmermann NA
    PLoS Pathog; 2015 Jul; 11(7):e1005049. PubMed ID: 26181057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse Model of Cytomegalovirus Disease and Immunotherapy in the Immunocompromised Host: Predictions for Medical Translation that Survived the "Test of Time".
    Reddehase MJ; Lemmermann NAW
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30563202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation.
    Hebart H; Daginik S; Stevanovic S; Grigoleit U; Dobler A; Baur M; Rauser G; Sinzger C; Jahn G; Loeffler J; Kanz L; Rammensee HG; Einsele H
    Blood; 2002 May; 99(10):3830-7. PubMed ID: 11986243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
    Wu Z; Qin R; Wang L; Bosso M; Scherer M; Stamminger T; Hotter D; Mertens T; Frascaroli G
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.